Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00326105
What this trial is testing

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Who this might be right for
Major Depressive Disorder
AstraZeneca 450
Not applicableLooking for participantsNCT07031817
What this trial is testing

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Who this might be right for
Bipolar Disorder (BD)Major Depressive Episode (MDE)Primary Care+1 more
University Hospital, Montpellier 623
Post-approval studies (Phase 4)UnknownNCT04138290
What this trial is testing

Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Taliaz Ltd. 30
Large-scale testing (Phase 3)Study completedNCT00130676
What this trial is testing

A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 257
Post-approval studies (Phase 4)Ended earlyNCT00926835
What this trial is testing

Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Ministry of Health & Welfare, Korea 692
Not applicableLooking for participantsNCT06620276
What this trial is testing

ACT_for Alcohol Use Disorder and Depression

Who this might be right for
Depression - Major Depressive DisorderAlcohol Use Disorder
Centre hospitalier de l'Université de Montréal (CHUM) 30
Testing effectiveness (Phase 2)WithdrawnNCT05030623
What this trial is testing

The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Sadat City University
Testing effectiveness (Phase 2)Looking for participantsNCT07493317
What this trial is testing

Neutralizing Interleukin (IL)-6

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 60
Post-approval studies (Phase 4)Study completedNCT00208715
What this trial is testing

Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.

Who this might be right for
Major DepressionMental Health
Emory University 100
Not applicableStudy completedNCT07099235
What this trial is testing

Chart Review of Patients Undergoing Ketamine Treatments for Depression

Who this might be right for
Depression - Major Depressive Disorder
Sunnybrook Health Sciences Centre 250
Not applicableStudy completedNCT05035563
What this trial is testing

Impact of a Communication Strategy in the Prevention of Depressive Symptoms in Patients with Covid-19

Who this might be right for
Critical IllnessMechanical VentilationCovid19
Pontificia Universidad Catolica de Chile 350
Large-scale testing (Phase 3)Study completedNCT00034944
What this trial is testing

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)

Who this might be right for
Major Depressive Disorder
Merck Sharp & Dohme LLC 495
Large-scale testing (Phase 3)Study completedNCT02372799
What this trial is testing

Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)

Who this might be right for
Major Depressive Disorder
Forest Laboratories 473
Not applicableStudy completedNCT00194948
What this trial is testing

Treatment Choices for Improving Adherence and Outcome

Who this might be right for
Major Depression
Weill Medical College of Cornell University 60
Testing effectiveness (Phase 2)Study completedNCT00761306
What this trial is testing

Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 74
Not applicableEnded earlyNCT01353963
What this trial is testing

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Who this might be right for
Major Depressive DisorderVasomotor Symptoms
Pfizer 13
Testing effectiveness (Phase 2)Ended earlyNCT05323019
What this trial is testing

Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression

Who this might be right for
Treatment Resistant Major Depressive Disorder
Zylorion Health 6
Large-scale testing (Phase 3)Study completedNCT01667809
What this trial is testing

CBT vs RTW Intervention for Patients With Common Subclinical Mental Illness in Primary Care

Who this might be right for
Anxiety DisordersMajor DepressionStress Disorders+1 more
Karolinska Institutet 5
Testing effectiveness (Phase 2)Study completedNCT00610649
What this trial is testing

Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)

Who this might be right for
Depression
Merck Sharp & Dohme LLC 54
Not applicableStudy completedNCT02871141
What this trial is testing

Multimodal Imaging of ECT Effects

Who this might be right for
Major Depressive Disorder
Charite University, Berlin, Germany 68
Next Page